{"id":1623829,"date":"2026-09-17T12:53:49","date_gmt":"2026-09-17T16:53:49","guid":{"rendered":"https:\/\/divine.ca\/?p=1623829"},"modified":"2026-09-17T13:05:46","modified_gmt":"2026-09-17T17:05:46","slug":"menopause-conversation-no-ones-having-guide-to-bhrt","status":"publish","type":"post","link":"https:\/\/divine.ca\/en\/menopause-conversation-no-ones-having-guide-to-bhrt\/","title":{"rendered":"The Menopause Conversation No One’s Having: A Guide to BHRT"},"content":{"rendered":"

It usually starts at around three in the morning. You are awake, the sheets are damp, and you are running through a list of likely culprits. Too much coffee. A stressful quarter at work. That second glass of wine. Menopause rarely makes the list first, and when it finally does, most women keep the thought to themselves.<\/span><\/p>\n

That silence is the real problem. Women talk openly about fertility, mental load, burnout and skincare. Hormonal change touches sleep, mood, memory, joints and libido all at once. Yet it still gets handled in whispers, or not at all. This guide is here to make the talk easier. It starts with the option that raises the most questions and the most confusion:<\/span> bioidentical hormone therapy<\/span><\/a>, often shortened to BHRT.<\/span><\/p>\n

Why the Silence Costs More Than Comfort<\/b><\/h2>\n

Most of us assume hot flashes arrive, hang around for a season, then politely leave. The data says otherwise. The Study of Women’s Health Across the Nation tracked thousands of women through the transition. Its 2015 report in JAMA Internal Medicine found that frequent hot flashes and night sweats lasted a median of 7.4 years. They carried on for a median of 4.5 years after the last period. For some groups of women, the figure stretched past a decade.<\/span><\/p>\n

Seven years is not a phase. It is a stretch of life that overlaps with career peaks, teenagers and aging parents. Many women spend the first two or three of those years quietly troubleshooting their own bodies. Nobody says the word perimenopause out loud.<\/span><\/p>\n

Part of the hesitation is historical. News coverage in the early 2000s left a generation sure that any hormone treatment was risky. That message stuck far longer than the science behind it. Medical bodies have since revisited the picture. On November 10, 2025, the Society of Obstetricians and Gynaecologists of Canada restated its guideline position. Menopausal hormone therapy is the most effective option for hot flashes and night sweats. It can be safely started in women without contraindications who are younger than 60, or less than 10 years past menopause. Programs that offer bioidentical hormone therapy build their intake around that same window. It is why timing comes up at the first visit rather than the fifth.<\/span><\/p>\n

What “Bioidentical” Actually Means<\/b><\/h2>\n

The word sounds like marketing, and it is often used that way. In medicine it has a narrow and useful meaning. A bioidentical hormone has the same structure as the one your own ovaries make. Estradiol is estradiol, whether your body made it or a lab did. The same holds for micronized progesterone.<\/span><\/p>\n

Here is the part that surprises people. Bioidentical does not have to mean custom-mixed. Many of these hormones already come as approved products with set doses. Skin patches and gels deliver estradiol. Capsules deliver micronized progesterone. The Canadian Menopause Society’s Pocket Guide to Menopause Management does not call one route best for everyone. It does name a patch or gel as the preferred route for certain groups. Those include smokers, and women with migraine, high triglycerides, metabolic syndrome, high blood pressure or diabetes. The same goes for women at raised risk of a blood clot. Where the uterus needs protecting, it pairs that route with micronized progesterone.<\/span><\/p>\n

The truly different category is custom-compounded therapy. A pharmacy mixes it to order for one patient. In 2020, the National Academies of Sciences, Engineering, and Medicine reviewed the evidence on these products. It found they lack the safety and efficacy data that approved products carry. The report advised keeping them for two narrow cases. One is a documented allergy to an ingredient in an approved product. The other is a documented need for a dose form that is not made as an approved one. It also said patient preference alone is not a reason to pick them. The Menopause Society draws the same line in its patient guidance.<\/span><\/p>\n

A Quick Comparison<\/b><\/h3>\n\n\n\n\n\n\n\n\n\n
<\/td>\nApproved bioidentical products<\/b><\/td>\nCustom-compounded preparations<\/b><\/td>\n<\/tr>\n
Molecular structure<\/i><\/b><\/td>\nIdentical to your own hormones<\/span><\/td>\nIdentical to your own hormones<\/span><\/td>\n<\/tr>\n
Dose consistency<\/i><\/b><\/td>\nStandardized and batch-tested<\/span><\/td>\nVaries between batches and pharmacies<\/span><\/td>\n<\/tr>\n
Regulatory review<\/i><\/b><\/td>\nChecked for safety, quality and efficacy<\/span><\/td>\nNot reviewed by Health Canada or the FDA<\/span><\/td>\n<\/tr>\n
Evidence base<\/i><\/b><\/td>\nStudied in clinical trials<\/span><\/td>\nLimited published outcome data<\/span><\/td>\n<\/tr>\n
Typical forms<\/i><\/b><\/td>\nPatches, gels, capsules, vaginal preparations<\/span><\/td>\nCreams, troches, pellets, custom blends<\/span><\/td>\n<\/tr>\n
Guideline position<\/i><\/b><\/td>\nRecommended first, where suitable<\/span><\/td>\nReserved for specific clinical situations<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Some clinicians pitch compounded hormones as safer or more natural than approved ones. The current evidence does not back that up. It is a fair thing to question, politely, in the room.<\/span><\/p>\n

Who Tends to Be a Candidate<\/b><\/h2>\n

No single profile fits everyone. Candidacy is a clinical decision that rests on your history and your labs. Still, hormone therapy comes up more often when several of these apply:<\/span><\/p>\n